- Home
- ARBE vs CATX Comparison
ARBE vs CATX Comparison
Compare ARBE & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- CATX
- Stock Information
- Founded
- ARBE 2015
- CATX 1983
- Country
- ARBE Israel
- CATX United States
- Employees
- ARBE N/A
- CATX N/A
- Industry
- ARBE EDP Services
- CATX Medical/Dental Instruments
- Sector
- ARBE Technology
- CATX Health Care
- Exchange
- ARBE Nasdaq
- CATX Nasdaq
- Market Cap
- ARBE 203.2M
- CATX 239.0M
- IPO Year
- ARBE N/A
- CATX N/A
- Fundamental
- Price
- ARBE $1.30
- CATX $3.35
- Analyst Decision
- ARBE Buy
- CATX Strong Buy
- Analyst Count
- ARBE 2
- CATX 11
- Target Price
- ARBE $1.75
- CATX $12.90
- AVG Volume (30 Days)
- ARBE 1.1M
- CATX 633.7K
- Earning Date
- ARBE 08-07-2025
- CATX 08-13-2025
- Dividend Yield
- ARBE N/A
- CATX N/A
- EPS Growth
- ARBE N/A
- CATX N/A
- EPS
- ARBE N/A
- CATX N/A
- Revenue
- ARBE $536,000.00
- CATX $1,235,000.00
- Revenue This Year
- ARBE $301.82
- CATX N/A
- Revenue Next Year
- ARBE $250.52
- CATX N/A
- P/E Ratio
- ARBE N/A
- CATX N/A
- Revenue Growth
- ARBE N/A
- CATX N/A
- 52 Week Low
- ARBE $0.85
- CATX $1.60
- 52 Week High
- ARBE $5.09
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- ARBE 44.06
- CATX 43.79
- Support Level
- ARBE $1.16
- CATX $3.36
- Resistance Level
- ARBE $1.46
- CATX $3.68
- Average True Range (ATR)
- ARBE 0.07
- CATX 0.25
- MACD
- ARBE 0.02
- CATX -0.03
- Stochastic Oscillator
- ARBE 47.54
- CATX 20.00
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.